MST3 is involved in ENaC-mediated hypertension

Area of Science:

• Nephrology
• Cardiovascular Physiology
• Molecular Endocrinology

Background:

• Liddle syndrome, a form of inherited hypertension, results from increased epithelial sodium channel (ENaC) expression and subsequent sodium retention.
• Kidney sodium transporters, including ENaC, NKCC, and NCC, are crucial for maintaining sodium and blood pressure homeostasis.
• The Ste20 kinase family, including MST3, is implicated in the evolutionary regulation of sodium transporters.

Purpose of the Study:

• To investigate the role of Mammalian Ste20 kinase 3 (MST3) in blood pressure regulation and sodium homeostasis.
• To determine if MST3 influences blood pressure stability through modulation of sodium transport pathways, particularly ENaC.

Main Methods:

• Generation and analysis of MST3 hypomorphic (MST3+/-) and knockout (MST3-/-) mice to assess blood pressure, serum sodium, and potassium levels.
• In vivo assessment of the effects of the ENaC inhibitor amiloride on MST3-/- mice.
• In vitro studies using Madin-Darby canine kidney cells expressing kinase-dead MST3 to measure ENaC currents.

Main Results:

• MST3-/- mice exhibited significant hypertension, hypernatremia, and hypokalemia compared to control mice.
• Increased ENaC activity in the kidneys of MST3-/- mice contributed to hypernatremia and subsequent potassium secretion, causing hypokalemia.
• Amiloride treatment reversed the hypernatremia and hypokalemia in MST3-/- mice, confirming the role of ENaC.
• In vitro studies showed elevated ENaC currents in cells with deficient MST3 kinase activity.

Conclusions:

• MST3 plays a critical role in maintaining sodium homeostasis and blood pressure stability by regulating ENaC activity.
• Dysregulation of MST3 leads to hypertension through excessive sodium reabsorption via ENaC.
• This study identifies MST3 as a novel regulator of blood pressure through ENaC modulation.